Success Stories: A Specialized Analytics Senior Analyst from Nepal in the Field of Data Science Secures NIW Approval in Just 6 Days, Thanks to Our Distinctive Legal Strategy

Client’s Testimonial:

“Thank you North America Immigration Law Group for the thorough professional and smooth service for getting my I-140 NIW approved. I highly recommend others to use their services.”

On January 24^th, 2024, we received another EB-2 NIW (National Interest Waiver) approval for a Specialized Analytics Senior Analyst in the Field of Data Science (Approval Notice).

General Field: Data Science

Position at the Time of Case Filing: Specialized Analytics Senior Analyst

Country of Origin: Nepal

State of Residence at the Time of Filing: New Jersey

Approval Notice Date: January 24^th, 2024

Processing Time: 6 days (Premium Processing Requested)

Case Summary:

Our skilled team at North America Immigration Law Group was contacted by a senior analytics analyst from Nepal who was interested in filing an I-140 petition under the EB-2 category (National Interest Waiver). Given that our client has a Ph.D. in data science and engineering and significant experience making progress in the same field, he qualified for this particular visa category. 6 days following the filing of the case, our client received the approval with our diligent team’s full support. A special thanks to the premium processing upgrade.

The necessary EB-2 petition documents are listed below:

As our duty to help our client showcase his academic and professional achievements, we documented our client’s exceptional record of citation count (5 peer-reviewed journal articles (all of them first-authored), 2 conference articles (first-authored), 2 abstracts (one of them first-authored), and one preprint (first-authored)), which altogether gathered 45 citations from other scholars from all around the world.
Additionally, our client demonstrated his accepted experience in the field by reviewing the work of other scholars in the same field one time.
We evaluated his research work thoroughly and represented to the USCIS that our client aspires to continue his research on developing machine learning algorithms and minimal-code evaluation methods to boost efficiency in data handling and recommendation systems in order to significantly reduce computational costs and improve practical applications in sectors like e-commerce and healthcare.
We concluded that his research endeavor is of great importance because bolsters the global economy.
His research has also been supported with funding from the U.S. National Science Foundation (NSF). This funding support can only be used for studies that further the interests of the country, such as those that promote scientific progress, improve the welfare of the populace, or protect national security. Because our client’s proposed endeavor has both substantial merit and national importance, he satisfied this prong.

In this way, we were able to prove that our client’s research revolutionizes healthcare practices and catalyzes economic growth by making AI technologies more accessible and cost-effective for both healthcare organizations and businesses. The evidence submitted also included recommendation letters from unbiased, independent experts which our attorneys helped draft along with evidence of our client’s publications, memberships in organizations that require achievement as judged by recognized national or international experts, discussion of his work by others, and his judging the work of others as a peer reviewer for international journals. After considering the evidence, USCIS approved the NIW petition. We wish him the best of luck in his future endeavors.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.